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cigarette smoking, or renal failure, also frequently leads to
ulcer formation and tissue loss. Fortunately, there is usu-
ally little overlap between these two patient populations,
affording physicians the opportunity to treat one of the
disease processes without concern for the other.
Patients with venous ulceration are often successfully
treated with compression dressings, elastic stockings, leg
elevation, and topical wound care.4 Those individuals with
refractory ulceration will often benefit from ligation or
stripping of the greater saphenous vein (GSV) if superficial
venous reflux is present, or possibly venous valve recon-
struction in the presence of deep venous insufficiency. In
contrast, patients with arterial insufficiency are often effec-
tively treated with wound care and arterial reconstruction.
However, a minority of patients will have tissue loss
from combined arterial and venous insufficiency (CAVI).
Unfortunately, there have been no reports on the effec-
Venous insufficiency and resulting ulceration affects
1% to 3% of the population, with many individuals having
recurrent ulceration after initially successful treatment.1-3
Arterial insufficiency, especially in the presence of diabetes,
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Purpose: The purpose of this study was to determine the effectiveness of treatment of patients with combined arterial
and venous insufficiency (CAVI), evaluate variables associated with successful ulcer healing, and better define criteria
for interventional therapy.
Study design: We retrospectively reviewed the records of patients treated at four institutions from 1995 to 2000 with
lower extremity ulcers and CAVI. Arterial disease was defined as an ankle/brachial index less than 0.9, absent pedal
pulse, and at least one in-line arterial stenosis > 50% by arteriography. Venous insufficiency was defined as characteris-
tic clinical findings and duplex findings of either reflux or thrombus in the deep or superficial system. Clinical, demo-
graphic, and hemodynamic parameters were statistically analyzed with multiple regression analysis and correlated with
ulcer healing and limb salvage.
Results: Fifty-nine patients with CAVI were treated for nonhealing ulcers that had been present from 1 to 39 months
(mean, 6.4 months). All patients had edema. The mean ankle/brachial index was 0.55 (range, 0-0.86). Treatment
included elastic compression and leg elevation in all patients and greater saphenous vein stripping in patients with
superficial venous reflux. Fifty-two patients underwent arterial bypass grafting, three underwent an endarterectomy,
one underwent superficial femoral artery percutaneous transluminal angioplasty, and three underwent primary below-
knee amputation. For purposes of analysis, patients were divided into four groups according to the pattern of arterial
and venous disease and the success of arterial reconstruction. Group 1 consisted of 22 patients with a patent arterial
graft, superficial venous incompetence, and normal deep veins. Group 2 consisted of seven patients with a patent graft,
superficial reflux, and deep venous reflux. Group 3 included 22 patients with a patent graft and deep venous throm-
bosis (DVT), and group 4 included eight patients with an occluded arterial graft. Follow-up ranged from 2 to 47
months (mean, 21.6 months). Forty-nine patients remained alive, and 10 died of unrelated causes. During follow-up,
48 of the 56 treated arteries remained patent and eight occluded. Thirty-four ulcers (58%) healed, 18 ulcers (31%) did
not heal, and 7 patients (12%) required below-knee amputation for nonhealed ulcers and uncontrolled infection. No
patient with graft occlusion was healed, and 12 ulcers persisted despite successful arterial reconstruction. Twenty-one
(78%) of 27 patients undergoing greater saphenous vein stripping were healed, but none of these patients had DVT.
The mean interval from bypass graft to healing was 7.9 months. Thirty-two (68%) of 46 patients without prior DVT
were healed, whereas only two (15%) of 13 patients with prior DVT were healed, and this variable, in addition to graft
patency, was the only factor statistically significant in predicting healing (P < .05).
Conclusions: Ulcers may develop anywhere on the calf or foot in patients with CAVI, and healing requires correction of
arterial insufficiency. Patients with prior DVT are unlikely to heal, even with a patent bypass graft. Ulcer healing is a
lengthy process and requires aggressive treatment of edema and infection, and successful arterial reconstruction.
Patients with a prior DVT are unlikely to benefit from aggressive arterial or venous reconstruction. (J Vasc Surg
2001;33:1158-64.)
tiveness of treatment of these patients, and no formal
management protocols have been evaluated. Conse-
quently, these patients have been treated on an individual
basis without a standard approach. The success of the var-
ious treatments has never been evaluated, and formal rec-
ommendations for treatment are unavailable. The current
study was therefore undertaken to determine the effec-
tiveness of treatment of patients with CAVI, evaluate vari-
ables associated with successful ulcer healing, and better
define criteria for interventional management.
METHODS AND MATERIALS
Patient population. Fifty-nine patients with CAVI
treated at a university hospital and three university-
affiliated teaching institutions between 1995 and 2000
were identified through a retrospective chart review.
Patients were identified by reviewing the records of indi-
viduals undergoing arterial reconstruction for ulceration
or nonhealing wounds, and then selecting those patients
who had clinical signs of venous insufficiency that were
confirmed with noninvasive studies. There were 38 men
and 21 women, and their ages ranged from 34 to 92 years
(mean, 69 years). Risk factors for peripheral vascular dis-
ease included cardiac disease in 17, current or past ciga-
rette smoking in 30, hypertension in 38, diabetes in 34,
and renal insufficiency (defined as creatinine level > 1.5
mg/dL, hemodialysis, or a renal transplant) in 20.
Five patients had undergone a previous ipsilateral
lower extremity arterial reconstruction, and four had pre-
viously undergone a superfical venous operation, with
excision of varicose veins or strippping of either the GSV
or lesser saphenous vein (LSV). These procedures were
performed at other institutions before presentation with
the current ulcer. No patient had undergone a deep
venous reconstructive procedure or venous bypass graft.
All patients had been treated with leg elevation, topical
wound care, and either a compression dressing or elastic
compression stockings. Six patients (11%) were taking
warfarin sodium (Coumadin) because of prior DVT.
Diagnosis of both arterial and venous insufficiency was
made with clinical, radiographic, and hemodynamic param-
eters. Arterial insufficiency was defined as an ankle/
brachial index (ABI) less than 0.9, absent pedal pulses, and
at least one in-line arterial stenosis > 50% by arteriography.
Venous insufficiency required the presence of characteristic
clinical and duplex findings. These requirements included
the presence of edema, hyperpigmentation, varicose veins,
or skin induration in addition to skin breakdown. On
duplex examination, reflux or thrombosis was required in
either the GSV or deep veins of the affected extremity.
Patients with clear evidence of scarring and fibrosis indicat-
ing prior DVT were included in this study.
For patients with multiple ulcers, the largest ulcer was
used as the “index” ulcer for purposes of analysis. Infection
was defined as erythema, cellulitis extending away from the
wound, or radiographic evidence of underlying osteomyelitis.
Evaluation and treatment. After clinical examina-
tion and evaluation of the ulcer, patients with suspected
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CAVI underwent duplex scan to evaluate the deep and
superficial venous systems, as well as measurement of the
ABI to identify the presence of arterial insufficiency.
Arteriograms were obtained for patients without clinical
evidence of wound healing. These studies were obtained
at the time of presentation with the primary ulcer.
Individuals not undergoing arteriography, in whom the
presence of arterial insufficiency could not be conclusively
determined, were not included in this study. All patients in
this study had at least one arterial stenosis > 50% involving
the ipsilateral iliac artery, superficial femoral artery (SFA),
popliteal artery, or all three tibial arteries. Patients not
meeting these criteria were excluded from this review.
Patients were initially treated with leg elevation, topi-
cal wound care, and elastic compression stockings or a
compression dressing (Unna boot). Topical antibiotics
were not prescribed, but systemic antibiotics were used for
patients with evidence of infection. Individuals with sig-
nificant cellulitis or osteomyelitis were hospitalized for
intravenous antibiotics.
Stripping or ligation of the GSV was done for patients
with superficial venous incompetence that was thought to
be clinically significant in affecting ulcer healing. Some
procedures were performed before and some after arterial
bypass grafting. Two to 3 months were allowed to deter-
mine the success of the initial procedure. The LSV was
stripped or ligated at the same operation in patients with
concomitant LSV reflux. Patients were not evaluated for
veno-venous bypass graft or reconstruction of the deep
venous system. Wound debridement was performed at the
same time as arterial reconstruction. The sequence of pro-
cedures for patients undergoing both arterial reconstruc-
tion and venous excision depended on which procedure
was thought to be more likely to obtain satisfactory ulcer
healing. The dominant disease process was treated initially
and was determined primarily by the degree of arterial
insufficiency as determined by the ABI. If the ABI was less
than 0.6, the arterial disease was treated first.
No patient underwent radical debridement of the
leg or free tissue transfer. Skin grafts were used selec-
tively, often in conjunction with ulcer excision. Several
patients had previously undergone a failed skin graft
before vascular surgical evaluation. All patients were
treated with aspirin, and warfarin sodium (Coumadin)
was used for patients with recurrent DVT, patients with
previously failed arterial reconstructions, or patients
undergoing arterial bypass grafting thought to be a high
risk for occlusion. 
Follow-up. Follow-up (FU) of patients with CAVI
included clinical examination, measurement of ABI, arte-
rial waveforms, and graft duplex examination that was
based on a preestablished protocol. Studies were obtained
every 3 months for the first 2 years after bypass graft, and
then every 6 months thereafter. Patients often underwent
clinical examination by their primary care physician in
addition to examination by the vascular surgeon, provid-
ing further surveillance to detect recurrent ulceration.
Repeat venous duplex scans were selectively obtained on
patients without evidence of ulcer healing, often to deter-
mine if residual reflux was present in the superficial or per-
forating veins, because this was potentially amenable to
ligation or excision.
Statistical analysis. Initially, all patients were
included in the analysis, and then the results were reana-
lyzed after separating the patients into four groups accord-
ing to the pattern of arterial and venous disease and the
success of arterial reconstruction. Group 1 consisted of 22
patients with a patent arterial graft, superficial venous
incompetence, and normal deep veins. Group 2 consisted
of seven patients with a patent graft, superficial reflux, and
deep venous reflux. Group 3 included 22 patients with a
patent graft and deep venous thrombosis (DVT), and
group 4 included eight patients with an occluded arterial
graft. Patients with DVT were therefore placed in group 3
(patients with DVT and a patent graft) or group 4
(occluded graft) depending on the results of arterial
reconstruction. No operative intervention was undertaken
in patients with an acute DVT.
In the overall analysis including all 59 patients, clinical
parameters, patient demographic information, cardiovas-
cular risk factors, hemodynamic variables, nature and loca-
tion of the venous insufficiency, and wound characteristics
were statistically analyzed with multiple regression analysis
to determine their affect on ulcer healing (Table I).
Statistical comparisons were made with the Fisher exact t
test. Success was defined as complete ulcer healing with
resolution of any surrounding infection without ulcer
recurrence. Failure was defined as (1) incomplete wound
healing, (2) residual infection, or (3) major amputation.
Subsequently, each group was analyzed separately to
determine the effect of pattern of arterial and venous dis-
ease, as well as the success of arterial reconstruction, on
ulcer healing and outcome. The mean ABI, duration of
ulcer nonhealing, mean FU, and clinical result were deter-
mined separately for each group to allow for a more mean-
ingful comparison betwen groups.
The life-table method was used to determine cumula-
tive ulcer healing and limb salvage. Results were reported
in accordance with the suggested reporting standards for
lower extremity arterial reconstructions developed by the
Society for Vascular Surgery and the American Association
for Vascular Surgery.5 Statistical significance was defined as
a P value less than .05.
RESULTS
All patients. The 59 nonhealing ulcers had been
present from 1 to 39 months (mean, 6.4 months).
Twenty-three patients had recurrent ulcers, and 25
patients had multiple ulcers. Thirty-one individuals (53%)
had infection involving the ulcer, and 19 (32%) had gan-
grenous tissue. All patients had edema, and most had
brawny induration or hyperpigmentation. Twenty-five
ulcers were on the medial calf, 13 on the foot, 12 on the
lateral calf, and 9 over the tibia. On duplex scan, 36
patients (61%) had GSV reflux, 21 (36%) had deep venous
reflux, 15 (25%) had GSV thrombosis, 13 (22%) had
DVT, and 26 (44%) had two or more of these findings. Of
the 13 patients with DVT, seven had GSV reflux, and six
had a competent superficial venous system. The ABI
ranged from 0 to 0.86 (mean, 0.55).
Fifty-two patients underwent arterial bypass grafting,
three underwent an endarterectomy, one had SFA percu-
taneous transluminal angioplasty, and three underwent
primary below-knee amputation (BKA). It was initially
planned that these three patients treated with primary
BKA would undergo intervention to attempt to save their
leg. However, if the arteriogram showed no good arterial
reconstructive options, these three patients elected to
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Table I. Effect of independent variables on ulcer healing
Variable P value No. of patients Healed Not healed
DVT .001 12 2 11
Graft occlusion .001 8 0 8
ABI* .125
Deep venous reflux .189 21 10 11
Ulcer location* .222
Ulcer duration (>5 mo)* .242 31 16 15
Superficial venous thrombosis .244 15 7 8
Renal insufficiency .337 20 8 12
Superficial venous reflux .341
Hypertension .369 38 23 15
Sex (female) .369 21 11 10
Infection .424 31 17 14
Cigarette use .456 30 18 12
Postoperative ABI* .462
Diabetes .519 34 20 14
Age (> 69 y)* .597 32 19 13
Gangrene .602 19 11 8
*These parameters were analyzed as continuous variables or variables with multiple possible values in the regression analysis, and it was the multiple regres-
sion analysis that was used to determine the P value.
undergo BKA to control their pain and infection. In each
case, BKA was performed when satisfactory wound heal-
ing was extremely unlikely and control of pain or infection
was required. For the 52 arterial bypass grafts, the inflow
artery was the common femoral artery in 32 patients, the
deep femoral artery in 3, the SFA in 12, and the popliteal
artery in 5. All patients underwent bypass grafting with
autogenous vein, usually in the reversed configuration.
Ipsilateral saphenous vein was used preferentially, followed
by contralateral GSV, arm veins, and LSV. Because of ipsi-
lateral GSV varicosities, thrombosis, or severe reflux, 32
patients required the use of other autogenous venous con-
duits. No prosthetic grafts were used. The outflow artery
was the popliteal artery in 27, a tibial artery in 19, and a
pedal vessel in 6. No patient had acute ischemia or
required a fasciotomy.
FU ranged 2 to 47 months (mean, 21.6 months).
Forty-nine patients remained alive, and 10 patients died of
unrelated causes. During FU, 48 of the 56 treated arteries
remained patent, and eight occluded. With life-table
analysis, primary assisted graft patency was 94%, 79%, and
63% at 1, 2, and 3 years, respectively, (Table II, Figure).
The mean ABI improved from 0.55 to 0.73.Thirty-four
ulcers healed (58%), 18 ulcers (31%) did not heal, and 7
patients (12%) required BKA for nonhealed ulcers and
uncontrolled infection. No patient with graft occlusion
was healed, and 12 ulcers persisted despite intact in-line
flow to the foot. The mean interval from bypass graft to
healing was 7.9 months (range, 1-11 months). For
patients undergoing GSV stripping before arterial recon-
struction, 2 to 3 months were usually allowed to see if
healing could be obtained without arterial bypass graft. All
patients treated with GSV stripping in this review had
prior or  subsequent arterial reconstruction.
Demographic variables, clinical parameters, and radio-
logic findings were statistically analyzed to determine their
effect on wound healing (Table I). Thirty-two (70%) of 46
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patients without prior DVT were healed, in contrast to
only two (15%) of 13 patients with prior DVT. Graft
patency and prior DVT (P < .001) were the only factors
statistically significant in predicting healing. Diabetes,
renal insufficiency, deep or superficial reflux, ulcer loca-
tion, and the presence of infection did not affect outcome.
Group 1. Group 1 consisted of 22 patients with a
patent arterial graft, superficial venous reflux, and no evi-
dence of prior DVT. The ulcers had been present for a mean
of 5.2 months, and the mean ABI was 0.52. All patients
were treated with arterial reconstruction, and 19 had GSV
stripping. The mean FU was 19.8 months. Eighteen
patients remained alive, four patients died, and 21 (95%) of
the 22 ulcers healed.
Group 2. Group 2 included seven patients with a
patent arterial graft, superficial venous reflux, and deep
venous reflux. The ulcers had been present for a mean of
11.1 months (range, 2-39 months), and the mean preoper-
ative ABI was 0.56 (range, 0.40-0.8). All patients under-
went arterial reconstruction, and two had stripping of the
GSV. FU ranged from 15 to 44 months (mean, 26
months). During FU, six patients remained alive and one
patient died, and four of the ulcers healed and three
remained unhealed. All grafts remained patent in this
group, and the postoperative ABI ranged from 0.71 to 1.0.
Group 3. Group 3 included 22 patients with a patent
arterial reconstruction and prior DVT. All 22 patients had
evidence of prior DVT involving the common femoral
vein, superficial femoral vein, or popliteal vein, and nine of
these 22 had evidence of extension into the external or
common iliac vein as well. No patient had evidence of prior
DVT isolated to a calf or tibial vein. The mean duration of
ulcer nonhealing was 6.6 months, and the mean preopera-
tive ABI was 0.36. Treatment was arterial reconstruction in
19 patients and primary BKA in three. FU on these 22
patients ranged from 5 to 47 months (mean, 23 months).
During this time, four patients died, and 18 remained alive.
Life-table plot of assisted primary patency for patients undergoing arterial reconstruction.
Nine ulcers healed (41%), 8 ulcers remained unhealed
(36%), and 5 patients (13%) underwent BKA, including
the three who underwent primary BKA rather than arterial
bypass graft.
Group 4. Group 4 consisted of eight patients with
occluded arterial grafts. The ulcers in these patients had
been present from 2 to 9 months (mean, 5.8 months). Four
of these patients had superficial reflux, four had DVT, and
three had deep reflux (3 patients had more than one abnor-
mality). The mean preoperative ABI was 0.34. FU ranged
from 11 to 33 months (mean, 19.5 months), during which
time seven patients died and one remained alive. No ulcers
healed, and two patients required major amputation.
DISCUSSION
Incidence of CAVI. The incidence of CAVI is diffi-
cult to determine, and no studies have focused specifically
on this patient population. In addition, formal criteria for
defining arterial or venous insufficiency have not been
proposed, and consequently the determination of ulcers
attributable to a specific etiology has varied between
reports. In some studies an ABI less than 0.7 has been
used to identify patients with arterial insufficiency, and in
others an ABI less than 0.8 or 0.9 has been used.1,6-9 No
clinical or arteriographic criteria have been used.
Similarily, venous insufficiency has usually been deter-
mined by clinical findings, rather than noninvasive tests or
radiologic studies. Reversal of flow more than 1 second in
duration has been used to identify reflux,1,8 and acute or
chronic DVT can usually be determined with duplex scan.
However, these criteria have not been used to categorize
venous insufficiency in patients with CAVI and nonhealing
wounds. Nevertheless, studies have suggested that up to
26% of lower extremity ulcers may have a combined arterial
and venous component.8 Guest et al1 identified 29 patients
(15% of patients with leg ulceration), and Dunn et al6 iden-
tified 21 patients (30% of the study population) with CAVI.
Because the incidence of CAVI is relatively low, few centers
have treated sufficient numbers of patients to acquire
enough experience to identify the importance of clinical
parameters or make recommendations for treatment.
In this report, we have proposed criteria to identify
patients with combined arterial and venous disease. We
have defined arterial insufficiency as an ABI less than 0.9 in
the presence of an absent pedal pulse and a stenosis of at
least 50% by arteriography. Venous insufficiency required
clinical evidence of chronic venous disease and duplex find-
ings of deep reflux, superficial reflux, or DVT. Using these
criteria, we have identified 59 patients with CAVI and
lower extremity ulceration. To better determine the rela-
tionship between the various types of venous insufficiency
and ulcer healing, we have stratified our patient population
into four groups. In each of the first three groups, arterial
reconstruction was successful in restoring intact in-line or
pulsatile flow to the ulcer, with an appropriate increase in
the ABI. Presumably, failure to heal in these groups there-
fore reflects the underlying venous pathologic condition or
failure of treatment of the venous component. The fourth
group consists of patients with failed arterial reconstruc-
tion. It is not surprising that none of the ulcers successfully
healed in this group, because the patients had significant
residual arterial insufficiency (mean ABI, 0.55).
We found ulcers to occur at any location on the distal
leg and foot, with the predominance of wounds on the
medial and lateral ankle (gaiter region), similar to the find-
ings of most population-based studies.1 The mean duration
JOURNAL OF VASCULAR SURGERY
1162 Treiman et al June 2001
Table II. Life-table data analysis of assisted primary patency for infrainguinal arterial bypass grafts in 59 patients with CAVI
No. withdrawn patent due to
Interval No. of grafts No. of Interval Cumulative
(mo) at risk at start failed grafts Duration Death patency rate patency (%)
0-1 59 0 0 0 1.0 1.0
1-2 59 0 0 0 1.0 1.0
3-5 58 0 2 1 1.0 1.0
6-8 55 0 3 1 1.0 1.0
9-11 51 2 3 1 .959 .959
12-14 45 1 5 0 .976 .936
15-17 39 1 2 2 .973 .911
18-20 34 1 2 0 .970 .881
21-23 31 3 5 0 .895 .789
24-26 23 0 5 0 1.0 .789
27-29 18 2 3 0 .879 .694
30-32 13 0 1 0 1.0 .694
33-35 12 1 2 0 .909 .631
36-38 9 0 1 0 1.0 .631
39-41 8 0 3 0 1.0 .631
42-44 5 0 3 2 1.0 .631
45-47 2 0 2 0 1.0 .631
48-50 0 0 0 0 1.0 .631
of ulceration in our patients was 6.4 months, in contrast to
population-based studies where the ulcers are primarily
venous and the mean duration significantly longer.1,6 This
may also reflect our management approach, where ulcers
determined to have a combined component were usually
evaluated for interventional treatment shortly after surgical
evaluation was obtained, because we were concerned the
ulcers were unlikely to heal with conservative therapy.
Evaluation and management. After ulcer identifica-
tion and clinical evaluation, we obtained noninvasive tests
to help determine the etiology of the ulcer and guide
treatment. Patients with clinical findings of venous insuffi-
ciency without arterial insufficiency were treated with leg
elevation, compression of the wound, and saline dressings,
but were not included in this study. If significant superfi-
cial reflux was present and the wound appeared unlikely to
heal, was painful, or was recurrent, stripping of the GSV
was recommended. Our experience and the reports of
others have found that GSV stripping is usually effective,
even in the presence of DVT or deep venous reflux.
After confirmation of arterial insufficiency with nonin-
vasive studies, patients with arterial insufficiency and no
evidence of venous insufficiency underwent arteriography
and intervention on the basis of traditional indications for
arterial reconstruction. Patients with CAVI were treated
with leg elevation, topical wound care, and compression,
and then underwent intervention to improve either the
venous or arterial circulation. Arterial reconstruction was
usually performed first, followed by stripping of the GSV
in patients with superficial venous reflux. For those
patients with mild arterial insufficiency (ABI > 0.6) and
superficial venous reflux treated initially with GSV strip-
ping, 2 to 3 months were usually allowed to determine the
success of the venous procedure before arterial bypass
graft was performed. Although this is a retrospective
review and patients not requiring arterial reconstruction
were not included in this series, it was our experience that
few patients with CAVI healed after GSV stripping with-
out successful subsequent arterial bypass graft.
Effectiveness of treatment. Most lower extremity
ulcers will heal with conservative therapy.6 Most of these
ulcers are venous, however, and studies have not separately
evaluated ulcers with a combined arterial and venous etiol-
ogy. Guest et al1 found that 74% of all ulcers healed within
6 months without an arterial or venous operative proce-
dure. Dunn et al6 found that with the addition of either
arterial or venous surgery, up to 88% of all ulcers healed,
with a recurrence rate of only 18%. Again, however, many
of these patients did not have CAVI, and no consistent
approach to management was used in this report.
In our study, only 58% of ulcers in patients with CAVI
healed, despite treatment of venous disease and arterial
insufficiency. Twelve percent of patients required major
amputation for refractory pain or infection. Even more
discouraging is the recognition that 44 (87%) of 52 arte-
rial grafts remained patent, and 12 patients with patent
grafts were not cured. Our subgroup analysis is limited by
the relatively small number of patients in each group and
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the possibility, therefore, of a type II statistical error.
Nevertheless, our results found that patients with arterial
insufficiency, a normal deep system, and superficial venous
reflux (group 1) had a 95% incidence of sustained ulcer
healing after successful arterial reconstruction (patent
bypass graft) and GSV stripping. In contrast, successful
healing was obtained in only 50% of patients with superfi-
cial and deep venous reflux, even in the presence of a
patent graft (group 2). However, it is possible some of
these patients may have previously had occult or subclini-
cal DVT, with the only sequelae being deep venous reflux
and no evidence of fibrosis, contracture, or scarring. In
addition, patients with a prior DVT (group 3) were
unlikely to be healed, even with successful arterial recon-
struction, leg elevation, and compression therapy. Many of
these patients, however, had deep venous reflux and per-
forating vein incompetence. Therefore, a prior DVT is
clearly associated with failure to heal, but whether the eti-
ology is residual fibrosis or scarring, deep venous reflux,
deep venous hypertension, or associated perforating vein
incompetence and the development of subsequent super-
ficial venous hypertension cannot be conclusively deter-
mined from this clinical review. Finally, a failed arterial
reconstruction with residual arterial insufficiency was uni-
formly associated with failure to heal, suggesting that cor-
rection of arterial insufficiency is mandatory if ulcer
healing is to be obtained in these patients.
Effect of independent variables on outcome. In
our study, a patent graft and palpable pedal pulses were
required for ulcer healing. Interestingly, grafts that
occluded within 2 years were associated with either incom-
plete ulcer healing or early ulcer recurrence. Given the
altered venous and microcirculatory hemodynamics in
patients with associated venous disease, stronger perfusion
pressures may be required than in most patients with arte-
rial disease and nonhealing wounds. However, as discussed
earlier, the postoperative ABI, as well as the improvement
in ABI, did not predict successful ulcer healing. Healing in
these patients may require extended treatment, explaining
the ineffectiveness of temporary increases in arterial perfu-
sion. In addition, this may reflect a type II statistical error,
with an inadequate number of patients in this study to
detect a difference statistically.
We found patients with a prior DVT were unlikely to
be healed, but this was the only variable besides a patent
arterial bypass graft, statistically significant in predicting
outcome. This may reflect the severity of the microcircula-
tory hemodynamics and inflammation in the skin and sub-
cutaneous tissue in patients with CAVI. Because only 13
patients had a prior DVT and two of these patients were
healed, we cannot recommend that all patients with a prior
DVT be denied attempts at interventional treatment.
Interestingly, superficial venous reflux, ulcer size, and ulcer
location did not correlate with outcome. Again, however,
this may represent a type II statistical error, because limited
numbers of patients had each of these findings.
In addition, variables known to affect arterial graft
patency and healing of arterial ulcers including renal fail-
deep venous system and isolated superficial venous reflux
were likely to be healed after GSV stripping and arterial
bypass grafting. Patients with prior DVT are unlikely to be
healed, even with a patent bypass graft. However, no other
parameter was predicting of failure to heal. Patients and
physicians need to recognize that ulcer healing is a lengthy
process and requires aggressive treatment of edema, infec-
tion, and correction of arterial insufficiency.
We wish to thank Christine Gazak for her assistance
with statistical analysis.
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ure, diabetes, or failed previous bypass graft, did not affect
outcome. However, these variables become important to
the extent they affect the success of arterial reconstruction.
Again, however, the limited number of patients does not
allow to make strong recommendations about the treat-
ment of these patients.
Recommendations for management. Although we
recognize that this therapeutic regimen has resulted in
only 58% ulcer healing, it has allowed us to identify those
patients most likely to benefit from intervention. After
ulcer identification and evaluation, noninvasive studies
including ABI and venous duplex should be obtained.
Although not of proven benefit in patients with CAVI, leg
elevation and compression dressings should be initiated.
Arteriography should be obtained on patients with evi-
dence of arterial insufficiency, because we found no ulcers
healed in these patients without arterial intervention.
Superficial venous stripping is recommended for patients
with superficial venous reflux and normal deep veins
(group 1), because almost all of these patients were healed
after GSV stripping and arterial bypass graft. Patients with
DVT were unlikely to be healed in our study, but because
only 13 patients were identified in this category, we cannot
conclude arterial reconstruction or GSV stripping, if con-
comitant superficial reflux is present, should be withheld.
Prolonged treatment is likely to be required, because
patients with recurrent arterial insufficiency from graft
occlusion are never completely healed or they have recur-
rent ulceration. Graft surveillance to ensure bypass patency
is necessary, and duplex scan to document correction of
superficial venous reflux is reasonable, because further
surgery can correct residual reflux.
CONCLUSION
Ulcers may develop anywhere on the foot or calf in
patients with CAVI, and sustained healing requires correc-
tion of severe arterial insufficiency. Patients with a normal
